Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tingting Xu
Institution:
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
First Affiliated Hospital of Anhui Medical University
ORCID:
0009-0007-5642-299X
Observed ORCID:
0009-0007-5642-299X
OpenAlex ID:
A5100559135
Penpulimab, an anti-PD-1 antibody, for heavily pretreated metastatic nasopharyngeal carcinoma: a single-arm phase II study
2024
·
Xiaozhong Chen
, Wei Wang
, et al.
·
Signal Transduction and Targeted Therapy
·
27
Abstract CT011: Penpulimab versus placebo in combination with chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A global, multicenter, randomized, double-blind, phase 3 trial (AK105-304)
2025
·
Chaosu Hu
, Xiaozhong Chen
, et al.
·
Cancer Research
·
10
N6-methyladenosine-induced miR-182-5p promotes multiple myeloma tumorigenesis by regulating CAMK2N1
2024
·
Jing Bao
, Tingting Xu
, et al.
·
Molecular and Cellular Biochemistry
·
10
Bioinformatic Analysis of Key Biomarkers and Infiltrating Immune Cells in Nonalcoholic Fatty Liver Disease.
2024
·
Ge Chen
, Shunshun Jiang
, et al.
·
PubMed
Show more works
View as search
Works count:
4
Citation count:
47
H-index:
3
I10-index:
3
Year
Topic
Type